In autism spectrum disorders, many parents resort to alternative treatments and these are generally perceived as risk free. Among these, the most commonly used is the gluten-free, casein-free diet. The objective of this work was to conduct a systematic review of studies published from 1970 to date related to the gluten-free, casein-free diet in autism spectrum disorder patients. Few studies can be regarded as providing sound scientific evidence since they were blinded randomized controlled trials, and even these were based on small sample sizes, reducing their validity. We observed that the evidence on this topic is currently limited and weak. We recommend that it should be only used after the diagnosis of an intolerance or allergy to foods containing the allergens excluded in gluten-free, casein-free diets. Future research should be based on this type of design, but with larger sample sizes.
Gluten-Free, Casein-Free Diet: Background
So far, there are no curative treatments for this disorder; however, there is some hope of advances. 4 In this context, many parents have turned to alternative treatments [5] [6] [7] driven by the frustration and concern caused by the diagnosis rather than with sound justification, and this issue is compounded by the fact that the treatments are generally thought to be risk-free. These alternative treatments include the adoption of elimination diets, in particular the gluten-free, casein-free diet, 8 the focus of this paper.
In relation to this, the elimination of gluten implies the exclusion of all food items containing wheat, oats, barley or rye, that is, all flours, bread, rusks, pasta, pastries, and other bakery products made with these cereals, while the elimination of casein means no intake of dairy products: milk, including
breast milk, yogurt, cheese, butter, cream or ice cream, among others.
On the other hand, in relation to children with autism spectrum disorders, these diets involve significant changes to their routine and such changes can, in themselves, affect their eating behaviors. [9] [10] [11] Additionally, the adoption of elimination diets works against efforts to improve the social integration of such children, in that a personal diet is an isolating factor. 12 
Opioid Theory for Autism Spectrum Disorders
The most commonly cited theory to justify adoption of a gluten-free, casein-free diet is related to neurotransmitters 13 and concerns the release of peptides with an opioid activity in the intestines. After digestion, certain types of proteins could cross the intestinal mucosa intact, 14 if this were more permeable than normal-this being the case when it is impaired by immunologic factors or by lesions in the case of celiac disease. If these peptides, transported by the bloodstream, were to cross the blood-brain barrier and reach the central nervous system in large quantities, it would affect brain functioning. 15 The hydrolysis of proteins from cereals and milk would generate exogenous neuropeptides (exorphines) such as gluteomorphins from gluten and beta-casomorphins from casein.
It should, however, be highlighted that exorphins have a low affinity for opioid receptors and that in dietary proteins there are also amino acid sequences with antagonist activity on opioid receptors which, despite having been known of for many years, tend not to be considered in this context. 16 What is more, experiments have failed to find abnormally high concentrations of opioid peptides in either plasma or the nervous system of patients with autism spectrum disorders. 17 As for urinary excretion, urinary opioid peptides have not been detected in people with autism spectrum disorders using modern methods with great sensitivity and specificity (namely, mass spectrometry coupled with high-performance liquid chromatography). [18] [19] [20] 
Prevalence
The adoption of gluten-free, casein-free diet, as an alternative treatment, is a poorly studied phenomenon. In the literature, figures are highly variable, indicating that this approach is tried in 20% to 70% of cases. For instance, Harrington et al 6 
Behavior and Physiological Perspective
The first author to establish an association between the frequency and severity of schizophrenia and the intake of foods containing gluten and dairy products was Dohan: the foods' withdrawal improved symptoms and their reintroduction worsened them. 26, 27 Subsequently, Panksepp 28 suggested that the behavioral changes associated with autism were the result of an abnormal activation of the opioid system because of an excess of agonists in the brain. It has been considered that gluten from cereal and casein from dairy products could be responsible, as they are a source of ''exorphins,'' peptides with opioid activity. [29] [30] [31] [32] Considering publications since 1970, excluding theses or book chapters, we found relatively few original studies on elimination diets that analyze the impact of foods on behavior in autism spectrum disorders. Several of these studies demonstrated significant improvements in intervention vs control groups, and Whiteley et al 33 reported the appearance of a possible diet-related autism phenotype that seems to be emerging supportive of a positive dietary effect with slight improvement in certain groups with autism spectrum disorders. On the other hand, Sponheim 12 did not observe any improvement after introduction of the elimination diet, but rather behavioral regression due to stigmatization. Elder et al 34 and Seung et al 35 did not find any improvement in the behavior of participants in the intervention group.
Having discussed the questionable effectiveness of this nutritional intervention on cognitive-behavioral function, we will now assess its safety. Cornish 11 did not find any significant nutritional differences between children with autism spectrum disorders as a function of whether they were on the gluten-free, casein-free diet, similar to the findings of Johnson et al. 36 On the other hand, Arnold et al 37 observed a significantly lower concentration of amino acids, including tryptophan in children with autism spectrum disorders on gluten-free, casein-free diets. Higher homocysteine levels have been observed in patients on a gluten-free diet long-term compared to typically developing children, and this implies deficiencies in folates and vitamin B 6 , increasing cardiovascular risk in the medium and long term. [38] [39] [40] Mariani et al 41 reported that patients on a gluten-free diet had high intakes of proteins and lipids but low intakes of carbohydrates, fiber, calcium, and iron. In line with this, Marcason 42, 43 warns about the risk of gluten-free diets resulting in deficient intake of both macro-and micronutrients, the associated restrictions making it much more difficult to achieve a balanced diet than when a broader variety of foods are consumed.
Similarly, a casein-free diet could result in calcium deficiency. [44] [45] [46] [47] Aldamiz-Echevarria et al 48 indicated that 76% of patients on a casein-free diet had a total lipid intake within the recommended range, but 85% had high ratios of o6/o3 and low plasma levels of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), a similar pattern being described by Schuchardt et al. 49 Further, slower bone development was observed in children with autism spectrum disorders on a casein-free diet than among those without dietary restrictions, 50 while Neumayer et al 51 demonstrated that children with autism spectrum disorders had a lower bone density than controls. In this latter study, the total energy and macronutrient intakes did not differ significantly between groups, but the intakes of vitamin D and calcium were lower in children with autism spectrum disorders and this can be attributable to lower consumption or even the elimination of milk and other dairy products.
All the above justifies this systematic review of the studies published since 1970 concerning dietary restriction and its impact on autism spectrum disorders. Specifically, the objectives of this study were to determine, on the basis of the available scientific data, (1) the apparent efficacy and (2) any possible associated metabolic risks of dietary restrictions.
Methods
We conducted a systematic review of the medical literature related to gluten-free, casein-free type diets. The date of the last search was September 30, 2013. We based our search on the Medline database, in accordance with the proposals of the Spanish National Health System. In addition, we also consulted other databases: Cochrane Library, Scielo, ScienceDirect, and Embase. For the searches, we used the keywords gluten-free, casein-free diet, autism, Autism Spectrum Disorders (ASDs), and review, with the corresponding Boolean operators. This paper complies with the methodological norms established for the publication of systematic reviews 52,53 and the PRISMA recommendations. 54 We first retrieved systematic reviews and full original articles published from 1970 to 2013. These publications were then included in the analysis provided that the participants, of any age, met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, criteria for autism spectrum disorders; that they were put on a diet excluding gluten, casein or both; and that the outcome variables were related to the potential biomedical or behavioral symptoms of autism spectrum disorders. We did not restrict the searches by language. On the other hand, studies in which the diet was not under supervision of the researchers and any that did not report on health outcomes were excluded.
To guide the evaluation of the data in the papers retrieved, we defined levels of evidence, on the basis of their methodological quality in terms of the study design. We then established grades of recommendations for the planning of dietary guidelines for patients with autism spectrum disorders. For this classification of the evidence and recommendations, we employed an instrument proposed by the Scottish Intercollegiate Guidelines Network. 55 The scale proposes that 2 characteristics of the source be used for assessing the quality of the scientific evidence provided (level of evidence): the study design and the risk of bias. Numbers from 1 to 4 are used to rate the study design, whereas signs (þþ, þ, and -) indicate the assessed risk of bias, according to the degree of fulfillment of key criteria related to this potential risk ( Table 1 ). Based on this assessment of the quality of the scientific evidence in the source, grades are used ( Table 2) to classify the strength of associated recommendations (A, B, C, and D).
In addition to the aforementioned system of levels, we considered the following features, as applicable, to assess the level of evidence provided by the selected articles: (A) Degree of homogeneity of the group studied (as determined by definitions and criteria applied); High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1þ
Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias 1-Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias 2
2þþ
High-quality systematic reviews of case-control or cohort or studies. 2þ
High-quality case-control or cohort studies with a very low risk of Confounding, bias, or chance and a high probability that the relationship is casual 2-
Well-conducted case-control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is casual 3
Nonanalytic studies, eg, case reports, case series 4
Expert opinion Abbreviation: RCT, randomized controlled trial. Source: SIGN, Scottish Intercollegiate Guidelines Network (2008). 
Grades of recommendation Definition
A At least 1 meta-analysis, systematic review, or RCT rated as 1þþ, and directly applicable to the target population; or a systematic review of RCTs or a body of evidence consisting principally of studies rated as 1þ, directly applicable to the target population, and demonstrating overall consistency of results B
A body of evidence including studies rated as 2þþ, directly applicable to the target population, and demonstrating overall consistency of results; or extrapolated evidence from studies rated as 1þþ or 1þ C A body of evidence including studies rated as 2þ, directly applicable to the target population, and demonstrating overall consistency of results; or extrapolated evidence from studies rated as 2þþ D Evidence level 3 or 4; or extrapolated evidence from studies rated as 2þ
Abbreviation: RCT, randomized and controlled trial. Source: SIGN, Scottish Intercollegiate Guidelines Network (2008). The studies classified as 1-or 2-were not used in the recommendation process given the high risk of bias. The studies classified as 1-and 2-were not used for establishing the recommendations given their high risk of bias.
treatments provided, or the use of 1 or more intervention procedures that could affect the assessment criteria selected. For evaluating and synthesizing the scientific evidence, we also considered the internal validity of the studies, whether there was statistical significance and the accuracy of the results, as well as their clinical relevance. We then characterized the recommendations on the basis of the quantity, generality, and clinical relevance of the results as well as the quality of the scientific evidence.
Results
The studies retrieved were analyzed in terms of the following characteristics, as applicable: sample size, study design, assessment and intervention criteria, and the results, as well as the level of evidence and the grade of recommendation. Tables 3  and 4 summarize the characteristics of the studies, the results of which have been referred to above.
Effectiveness
Scientific literature on this topic is relatively scarce. Among the studies that refer to effectiveness, only four 12, 34, 35, 56 can be considered to provide high scientific evidence. The studies of Harland 57 and Hyman 58 are not yet completed. Millward 59 and Mulloy 60,61 present systematic reviews evaluated with the highest level of evidence and grade of recommendation. Notably, in our analysis, the studies that reported positive results were classified with the lowest levels of evidence, whereas the rest reported negative results with regards to this type of dietary intervention. None of the studies identified provided conclusive evidence because they had poor validity (Table 3) .
Safety
There are similarly few publications addressing the safety of the gluten-free, casein-free diet. Among those identified, the studies of Konstantynowicz et al 46 and Hediger et al 50 provide the highest level of evidence. Nevertheless, in the results found, there was a certain degree of consensus on the risks that could be associated with following this type of restriction diet (Table 4 ).
Discussion
Data in the literature in this field are very limited both in quantity and quality. To assess the effectiveness and safety of the gluten-free, casein-free elimination diet, we considered both behavioral (verbal and nonverbal communication, stereotypy, and disruptive behavior) and biomedical variables (eg, urinary peptides, gliadin and endomysial antibodies, as well as other laboratory data and nutrient intake). Methodologic limitations identified were associated with a range of factors: the lack of a control group and/or clear definitions of inclusion criteria, very small sample sizes, and analysis being based on single individuals or anecdotal information, groups being heterogeneous in terms of age, failure to control for phenotypic variability between individuals, interventions being of variable duration and generally short, as well as lack of preintervention-postintervention comparisons. There was also a risk of bias in data on the behavioral variables attributable to memories of parents and other caregivers being distorted over time and that their perception of changes in the behavior of participants can be subjectively influenced by the fact of being included in nonblinded trials. Similarly, a placebo effect could have had an impact on the results. Lastly, alternative explanations were not always considered, such as the risk of confounding bias, in particular, it being possible that behavioral improvements were due to ongoing development and behavioral therapy given, rather than to gluten-free, casein-free diets per se. Finally, it should be noted that the literature search cannot have identified all the relevant publications, and the review itself can be sensitive to information bias.
Recommendations
On the basis of this review, we conclude that the evidence to support gluten-free, casein-free diets is limited and weak, such dietary restrictions being associated with social rejection, stigmatization, deficits in socialization and integration, and a misuse of resources, as well as potential adverse biomedical effects. Hence, we advise against resorting to elimination diets in an attempt to treat autism spectrum disorders. Specifically, until there is conclusive evidence of the benefits of glutenfree, casein-free diets in autism spectrum disorders, they should only be introduced after the diagnosis of an intolerance or allergy to allergens in the foods that would be eliminated in such a diet. Similarly, the results retrieved do not support the opioid theory.
Implications for the Practice
As a final recommendation, we underline that, when used, elimination diets must be at least as closely monitored as other types of intervention, to allow doctors, parents, and other caregivers to optimize treatments and hence health outcomes for these children. On the other hand, a diet-related specific end phenotype can be a target for future research and even a marker for the gluten-free, casein-free dietary intervention.
Based on the results of this review, future research should be focussed on blinded randomized controlled trials, and include larger samples sizes.
